Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Shuttle Pharmaceuticals (SHPH) Stock Soars 70% After Its IPO

Today, investors in SHPH stock appear to be pushing the price of this speculative stock higher, but buyers should beware on this one.

3 Cryptos That Could 10X by 2032

Investors looking for cryptos that could 10X certainly have a wide range of options to consider, but here are three top picks.

3 No-Brainer Cryptos to Buy If You Have Money to Invest

These three no-brainer cryptos to buy are tokens which have been beaten up by the market, but which provide intriguing upside potential.

bioAffinity (BIAF) Stock Pops 100% in Red-Hot IPO

Today, investors in bioAffinity and BIAF stock saw major gains as this stock surged more than 100% at one point during today's session.

Terra Classic Price Predictions: Where Will LUNC Go After Major Rally?

Investors interested in Terra Classic price predictions have a lot to be excited about this week, with token burns making headlines.